Helping promising biotech deliver innovative medicines to patients faster

Clinical translation at cost price, business development support and regulatory guidance for promising Life Science ventures.

“The fact that TRACER invited us to be part of their Excellence Program is a confirmation of our project ́s scientific merits and it leverages our continued development of ANXV as a therapy for RVO"
Anders Haegerstrand - CEO Annexin Pharmaceuticals AB

Get your drug to patients faster

If accepted, you receive full support in the (pre-) clinical translation of your compound at cost price, business development support and regulatory guidance.

Clinical translation at cost price

We will manage the clinical translation of your compound till phase III at cost price, starting by generating fast in-human data on the efficacy of your drug. This saves up to 40% of the regular R&D costs. Additionally, TRACER does not gain equity nor requires IP sharing from the participating companies.

Business Development support

Together will define business goals for your venture to generate a high return on investment for all stakeholders involved. As a participant you are also introduced to a large European and U.S. network. This allows you to expand your strategic partnerships and find potential exit partners.

Regulatory guidance & design

Our team has extensive know-how in creating the most efficient regulatory path for testing a new drug. They will advise you on how to develop your compound in a way that fits the market and will, together with you, develop FDA and/or EMA compliant clinical development plans.

Meet our experts

You will work closely together with a team that has many years of experience in the Life Sciences industry in both international business and scientific expertise.

Go van Dam | MD, PhD

Chief Executive Officer

A pioneer in the optical imaging field with ground breaking research to his name.

Ari Aminetzah | MBA, PhD cand.

Chief Business Officer

A life science veteran with 25+ years of international experience in the industry.

Maarten Brom | PhD

Director of Nuclear Imaging

A seasoned scientist, specialised in chemistry and nuclear imaging.

FAQ

Contact us

Got any questions? Don't hesitate to reach out.

Made with